Michael Narachi Insider Profile
4 Followers
Michael Narachi, Director at Ultragenyx Pharmaceutical, holds 40.44K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 60.51K shares in Orexigen (Ticker: OREXQ), holds 62.50K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ).
Michael Narachi has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Narachi's holdings
Insider Roles
Director
Roles that Michael Narachi holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Narachi
Michael Narachi's Trading History
Ultragenyx Pharmaceutical
May 18, 2026
Director
Uninformative Buy
―
$626.03K
Orexigen
Jun 02, 2017
―
Uninformative Buy
970.30
$302.54
Eiger Biopharmaceuticals
Feb 06, 2014
―
Informative Buy
500.00K
$531.25K
Amag Pharmaceuticals
May 24, 2013
―
Uninformative Buy
―
$328.63K
List of latest transactions for each holding click on a transaction to see Michael Narachi's performance on stock
You May Also Like
Michael Narachi insider profile FAQ
What is the percentage of profitable transactions made by Michael Narachi?
The percentage of profitable transactions made by Michael Narachi is ―.
What is the average return per transaction made by Michael Narachi?
The average return per transaction made by Michael Narachi is ―.
What stocks does Michael Narachi hold?
Michael Narachi holds: RARE, OREXQ, EIGRQ, AMAG stocks.
What was Michael Narachi’s latest transaction?
Michael Narachi latest transaction was an Uninformative Buy of ―.
What was Michael Narachi's most profitable transaction?
Michael Narachi’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Narachi's role in Ultragenyx Pharmaceutical?
Michael Narachi's role in Ultragenyx Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.